COMMUNIQUÉS West-GlobeNewswire

-
Sienna Announces December Dividend
15/12/2017 -
Orphazyme assumes sponsorship of Phase II/III sIBM trial
15/12/2017 -
Polydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results
15/12/2017 -
Global Blood Therapeutics Prices a $100.0 Million Common Stock Public Offering
15/12/2017 -
RespireRx Pharmaceuticals Inc. Officers and Directors Elect to Forgive $2,356,733 of Past Due Cash Compensation and Receive Non-Qualified Stock Options to Reduce Balance Sheet Debt
15/12/2017 -
OrthoPediatrics Corp. Appoints Samuel D. Riccitelli to its Board of Directors
15/12/2017 -
Aquinox Promotes Lloyd Mackenzie to Chief Operating Officer and Vice President, R&D Operations
15/12/2017 -
Progressive Care Reports Strong November Sales to Begin End of Year Rally
15/12/2017 -
Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion for the Treatment of X-Linked Hypophosphatemia in Children
15/12/2017 -
Northern Vine Labs Expands Dealer’s License with Health Canada
15/12/2017 -
Mersana Therapeutics Added to NASDAQ Biotechnology Index
15/12/2017 -
PolarityTE™ Announces Application of SkinTE™ on First Patients
15/12/2017 -
Tetraphase Pharmaceuticals Added to NASDAQ Biotechnology Index
15/12/2017 -
IBEX Reports First Quarter Fiscal 2018 Results
15/12/2017 -
Surgery Partners, Inc. Announces $50.0 Million Share Repurchase Program
15/12/2017 -
Extendicare Announces December 2017 Dividend of C$0.04 per Share
15/12/2017 -
American Health Council Names Leslie Fletcher, BSN, RN, MEP-C to Nursing Board
15/12/2017 -
Athenex Announces Initiation of an Oral Eribulin Investigational New Drug Development Program for Oncology Indications
15/12/2017 -
Endocyte Added to NASDAQ Biotechnology Index
15/12/2017
Pages